Kala Pharmaceuticals Inc (KALA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KALA | BMY | AMGN | GILD | VRTX |
| Company | Kala Pharmaceuticals Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.3100 | 74.16 | 247.63 | 65.02 | 293.23 |
| High | 0.3198 | 75.71 | 252.01 | 65.79 | 300.26 |
| Low | 0.3013 | 74.16 | 247.63 | 64.92 | 292.11 |
| Last | 0.3100 | 75.33 | 250.86 | 65.34 | 299.04 |
| Change | -0.0139 | +1.18 | +1.16 | +0.16 | +4.75 |
| % Change | -4.29% | +1.59% | +0.46% | +0.25% | +1.61% |
| Volume | 517,200 | 7,937,500 | 2,207,200 | 5,258,000 | 1,091,500 |
| 20-Day Average Volume | 971,415 | 8,297,870 | 2,406,435 | 6,732,635 | 1,399,505 |
| Previous Close | 0.3239 | 74.15 | 249.70 | 65.18 | 294.29 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.3268 | 74.01 | 248.93 | 62.40 | 289.10 |
| 20-Day Raw Stochastic | 14.29% | 90.27% | 73.32% | 79.61% | 79.88% |
| 20-Day Relative Strength | 40.80% | 53.23% | 54.61% | 60.62% | 57.49% |
| Weighted Alpha | -91.66 | +13.02 | +14.30 | -6.14 | +55.68 |
| Today's Opinion | 100% Sell | 32% Buy | 88% Buy | 24% Buy | 100% Buy |
| Previous Opinion | 100% Sell | 16% Buy | 88% Buy | 24% Buy | 100% Buy |
| Last Month's Opinion | 88% Sell | 40% Buy | 80% Buy | 56% Sell | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.77% since 08/12/22 | -0.32% since 08/12/22 | +0.99% since 08/12/22 | +3.78% since 08/12/22 | +1.53% since 08/12/22 |
| Low | 0.3013 on 08/19/22 | 73.62 on 08/18/22 | 247.63 on 08/19/22 | 63.66 on 08/15/22 | 291.45 on 08/18/22 |
| High | 0.3400 on 08/16/22 | 75.71 on 08/19/22 | 254.16 on 08/16/22 | 66.89 on 08/17/22 | 305.95 on 08/15/22 |
| 1-Month | |||||
| %Chg | -10.61% since 07/19/22 | +2.99% since 07/19/22 | +1.43% since 07/19/22 | +5.18% since 07/19/22 | +3.26% since 07/19/22 |
| Low | 0.2900 on 08/11/22 | 71.71 on 08/05/22 | 241.79 on 08/05/22 | 59.27 on 08/01/22 | 271.61 on 08/03/22 |
| High | 0.4300 on 08/11/22 | 75.72 on 08/12/22 | 254.16 on 08/16/22 | 66.89 on 08/17/22 | 305.95 on 08/15/22 |
| 3-Month | |||||
| %Chg | -54.51% since 05/19/22 | -0.83% since 05/19/22 | +2.49% since 05/19/22 | +3.27% since 05/19/22 | +17.06% since 05/19/22 |
| Low | 0.2810 on 07/01/22 | 71.71 on 08/05/22 | 229.49 on 06/17/22 | 57.17 on 06/14/22 | 243.17 on 06/14/22 |
| High | 0.8499 on 05/23/22 | 80.59 on 06/27/22 | 257.97 on 06/01/22 | 66.89 on 08/17/22 | 305.95 on 08/15/22 |
| 6-Month | |||||
| %Chg | -56.66% since 02/18/22 | +11.52% since 02/18/22 | +13.63% since 02/18/22 | +7.03% since 02/18/22 | +30.24% since 02/18/22 |
| Low | 0.2810 on 07/01/22 | 66.19 on 02/24/22 | 214.39 on 02/24/22 | 57.17 on 06/14/22 | 225.28 on 02/24/22 |
| High | 1.9400 on 03/16/22 | 80.59 on 06/27/22 | 258.45 on 04/11/22 | 66.89 on 08/17/22 | 305.95 on 08/15/22 |
| Key Statistics | |||||
| Market Capitalization, $K | 23,712 | 158,329,152 | 133,572,280 | 81,694,464 | 75,473,328 |
| Shares Outstanding, K | 73,208 | 2,135,255 | 534,931 | 1,253,367 | 256,459 |
| Annual Sales | 11,240,000 | 46,385,000,000 | 25,979,000,000 | 27,305,000,000 | 7,574,400,000 |
| Annual Net Income | -142,610,000 | 6,994,000,000 | 5,893,000,000 | 6,225,000,000 | 2,342,100,000 |
| Last Quarter Sales | 2,100,000 | 11,887,000,000 | 6,594,000,000 | 6,260,000,000 | 2,196,200,000 |
| Last Quarter Net Income | -28,110,000 | 1,421,000,000 | 1,317,000,000 | 1,144,000,000 | 810,500,000 |
| 60-Month Beta | 1.04 | 0.40 | 0.56 | 0.34 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.38 on 08/11/22 | 1.93 on 07/27/22 | 4.65 on 08/04/22 | 1.58 on 08/02/22 | 3.60 on 08/04/22 |
| Latest Earnings Date | 08/11/22 | 07/27/22 | 08/04/22 | 08/02/22 | 08/04/22 |
| Most Recent Dividend | N/A | 0.540 on 06/30/22 | 1.940 on 08/17/22 | 0.730 on 06/14/22 | N/A |
| Next Ex-Dividends Date | N/A | 06/30/22 | 08/17/22 | 09/14/22 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 9.66 | 13.98 | 9.38 | 23.30 |
